10-Q quarterly report · filed Nov 5, 2026

Zoetis (ZTS) Q3 2026 10-Q Quarterly Report

Short answer

Zoetis (ZTS) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $2.4B (down 0.4% year over year) with net income of $591M.

Q3 2026 key financials · XBRL

Revenue
$2.4B
−0.4% YoY · −3.1% QoQ
Net income
$591M
−18.0% YoY · −14.5% QoQ
EPS (diluted)
$1.43
−12.3% YoY · −13.9% QoQ

Source: XBRL data from the Zoetis (ZTS) Q3 2026 10-Q on SEC EDGAR. USD.

Zoetis Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Q3 revenue $2,391M, down $31M or 1% YoY, operational revenue down 2%
  • Q3 cost-of-sales margin 70.8% vs 71.2% YoY, gross margin U.S. 82.2% vs 83.2%, International 68.9% vs 68.2%
  • Best segment International: revenue $1,116M, up 4%; worst U.S.: revenue $1,246M, down 6%
  • Nine-month operating cash flow $1,880M vs $2,056M; financing outflows $2,371M, including $1,659M share repurchases
  • Headwinds: softer companion-animal demand, generic competition, tariffs, inflation, geopolitical uncertainty and foreign-exchange volatility

Risk Factors

  • No material changes to risk factors disclosed in Zoetis’s 2025 Form 10-K
  • Regulatory compliance risk: Existing 10-K risks remain incorporated by reference
  • Operational risk: Existing MD&A operating-environment risks remain relevant to results
  • Financial risk: Existing 10-K financial-condition risks remain unchanged

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Zoetis quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.